Form 8-K - Current report:
SEC Accession No. 0000950170-25-085380
Filing Date
2025-06-12
Accepted
2025-06-12 16:18:23
Documents
10
Period of Report
2025-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K dsgn-20250610.htm   iXBRL 8-K 61838
  Complete submission text file 0000950170-25-085380.txt   175066

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dsgn-20250610.xsd EX-101.SCH 26968
12 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-20250610_htm.xml XML 5111
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40288 | Film No.: 251042773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)